Previous 10 |
AUSTIN, Texas, March 12, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the fourth quarter and year ended December 31, 2018 on Thursday,...
AUSTIN, Texas, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ:VRML), a bioanalytical-based women’s health company focused on gynecologic disease, will ring the NASDAQ closing bell today. “September is an opportunity for us to reach more women and raise ...
Seasoned managed care leader with 30+ years of managed health experience AUSTIN, Texas, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML) , a bioanalytical-based women’s health company focused on gynecologic disease, today announced the appointment of Nanc...
News, Short Squeeze, Breakout and More Instantly...
Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First Quarter of 2022 Conference Call and Webcast sched...
AUSTIN, Texas, May 05, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021, after the market...
AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the 2020 Cantor Virtual Healthcare Conference taking place on September 15-17, 2020. Valeri...